NSE: MEDANTA - Global Health Limited

Yield per half year: -24.34%
Sector: Healthcare

Global Health Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
72.54 59.31 22.3% 57.4 +26.38%
P/S 10.59 8.62 22.88%
P/BV 11.94 6.53 82.75%
P/FCF 0.6835 0.6184 10.54%
Ev/Ebitda 38.82 141.72 -72.61%
Ev/S 10.7 8.63 24.01%
Ev/FCF 105.11 7.72 1261.57%
E/P 2.1 0.1367 1435.68%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
27.57 0.3647 7460.03% 21.69 +27.11%
ROE 16.45 7.22 127.82%
ROA 11.11 6.7 65.87%
ROIC 0 15.91 -100%
ROS 14.6 -4.66 -412.98%
ROCE 25.13 11.71 114.65%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.8879 123.39 -99.28% 1.92 -53.66%
Nеt Debt/Ebitda 0.4178 121.88 -99.66%
Debt/Ratio 0.1863 0.1698 9.73%
Debt/Equity 83.06 3.45 2310.95%
Debt/Net Income 1.68 3.06 -45.18%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 9.59 -100% 0 0%
Number of years of dividend growth 0 0.7073 -100%
DSI 0 0.8351 -100%
Average dividend growth 0 -2.19 -100%
Average percentage for 5 years 0 14.83 -100%
Average percentage for payments 0 24.67 -100%
Difference from average difference in sector -9.59

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
18482.15 695.45 2557.58%
Growth impulse Ebitda in 5 years 31406.16 617.6 4985.19%
Growth impulse Net Income in 5 years 110589.02 759.48 14461.15%
Growth impulse FCF in 5 years -212607.58 1011.9 -21110.73%
Growth impulse EPS in 5 years 103787.5 220.4 46990.52%
IP Score
4.88/10

Similar companies

IndusInd Bank Limited

Divi's Laboratories Limited

Sun Pharmaceutical Industries Limited

Cipla Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription